Nano‐encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus.

MLA

McCormick, Erika T., et al. “Nano‐encapsulated Anandamide Reduces Inflammatory Cytokines in Vitro and Lesion Severity in a Murine Model of Cutaneous Lupus Erythematosus.” Experimental Dermatology, vol. 32, no. 12, Dec. 2023, pp. 2072–83. EBSCOhost, https://doi.org/10.1111/exd.14935.

APA

McCormick, E. T., Draganski, A., Chalmers, S., Zahn, J., Garcia, S., Nussbaum, D., Friedman, A., Putterman, C., & Friedman, J. (2023). Nano‐encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus. Experimental Dermatology, 32(12), 2072–2083. https://doi.org/10.1111/exd.14935

Chicago

McCormick, Erika T., Andrew Draganski, Samantha Chalmers, Joseph Zahn, Sayra Garcia, Dillon Nussbaum, Adam Friedman, Chaim Putterman, and Joel Friedman. 2023. “Nano‐encapsulated Anandamide Reduces Inflammatory Cytokines in Vitro and Lesion Severity in a Murine Model of Cutaneous Lupus Erythematosus.” Experimental Dermatology 32 (12): 2072–83. doi:10.1111/exd.14935.